# Vicapsys Life Sciences, Inc.

Vicapsys Life Sciences, Inc. is a public company listed on OTC as VICP, headquartered in Cumming, GA, United States.

## Company overview

- **Legal name:** Vicapsys Life Sciences, Inc.
- **Former names in filing history:** SSGI, INC. (2009-07-17 to 2016-11-07)
- **Classification:** Public company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Cumming, GA, United States
- **Incorporated in:** FL
- **Fiscal year end:** December 31
- **Ticker:** OTC: VICP
- **SEC CIK:** 0001468639

## About

Vicapsys Life Sciences, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001468639, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2024-10-21, it reported net income of USD -1,182,112; total assets of USD 39,656 for the fiscal period ended 2023-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2023 (period ended 2023-12-31)

- **Net income:** -$1.2M (USD -1,182,112)
- **Total assets:** $39,656 (USD 39,656)
- **Cash and equivalents:** $9,422 (USD 9,422)
- **Operating cash flow:** -$417,524 (USD -417,524)

### FY2022 (period ended 2022-12-31)

- **Net income:** -$984,790 (USD -984,790)
- **Total assets:** $72,021 (USD 72,021)
- **Cash and equivalents:** $14,097 (USD 14,097)
- **Operating cash flow:** -$238,197 (USD -238,197)

### FY2021 (period ended 2021-12-31)

- **Net income:** -$236,871 (USD -236,871)
- **Total assets:** $594,313 (USD 594,313)
- **Cash and equivalents:** $217,295 (USD 217,295)
- **Operating cash flow:** -$443,974 (USD -443,974)

### FY2020 (period ended 2020-12-31)

- **Net income:** -$765,844 (USD -765,844)
- **Total assets:** $404,118 (USD 404,118)
- **Cash and equivalents:** $1,269 (USD 1,269)
- **Operating cash flow:** -$262,897 (USD -262,897)

## Recent SEC filings

- Form 10-Q — filed 2025-01-10 — period 2024-09-30
- Form 10-Q — filed 2025-01-10 — period 2024-06-30
- Form 10-Q — filed 2025-01-10 — period 2024-03-31
- Form 10-K — filed 2024-10-21 — period 2023-12-31
- Form 8-K — filed 2023-12-27 — period 2023-12-26
- Form 10-Q — filed 2023-11-14 — period 2023-09-30
- Form 10-Q — filed 2023-08-14 — period 2023-06-30
- Form S-1 — filed 2023-06-30
- Form 8-K — filed 2023-06-30 — period 2023-06-27
- Form 8-K — filed 2023-06-02 — period 2023-05-31
- Form 8-K — filed 2023-05-17 — period 2023-05-12
- Form 10-Q — filed 2023-05-15 — period 2023-03-31

---

Updated: 2026-10-23T06:52:41Z

Canonical page: https://altss.com/profile/vicapsys-life-sciences-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology